Data from the KIRC study confirmed that a lower INVS expression level in ccRCC was significantly related with the overall and disease-specific survival, as well as with a shorter progression-free interval (p < 0.05). This evidence concerns the gene INVS and nonpapillary renal cell carcinoma.